CoChat

Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke

Ali, Susanna Bortolusso, MooSang, Michelle, King, Lesley, Knight‐Madden, Jennifer, Reid, Marvin · 2011 · American Journal of Hematology
Cited by 50

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Chronic transfusion therapy is the treatment of choice for preventing stroke recurrence in children with sickle cell disease (SCD). The majority of children affected by this devastating complication live in the developing world where access to regular blood transfusions may be impractical. Since 2000, in the absence of regular blood supplies, all children at the Sickle Cell Unit who had experienced a first clinical stroke were offered hydroxyurea (HU) as the only intervention to prevent stroke recurrence. Forty‐four children were identified as having experienced a first clinical stroke between January 1, 2000 and September 30, 2009; one died at that presentation. Forty‐three children were therefore followed for 111 person‐years, of whom 10 (23.3%) agreed to start HU. Only one child in the HU group, incidence rate 2/100 person‐years, had clinical stroke recurrence, compared to 20/33 in the non‐HU group, incidence rate 29/100 person‐years (Hazard ratio (HR) 9.4 [95% Confidence interval (CI): 1.3–70.6];P= 0.03). When the groups were compared, in the non‐HU group, four died (vs. zero), 13 (53% vs. 10%) had moderate–severe physical disability (P= 0.017), and 12 (44% vs. 20%) required special education or were too disabled to attend school. Our data support the role of HU as a useful intervention for prevention of stroke recurrence in SCD when transfusion programs are not available or practical. Am. J. Hematol., 2011. © 2011 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajh.22142

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 50

Metadata

Authors
Ali, S. B., MooSang, M., King, L., Knight‐Madden, J., & Reid, M.
Venue
American Journal of Hematology
Publisher
Wiley
Published
2011-09-02
Volume
86
Issue
10
Pages
846-850
ISSN
  • 0361-8609 (ISSN-L)
  • 1096-8652
OpenAlex
W2062915958
Cited by
50
References
7
FWCI
2.02
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke. https://app.cochat.ai/papers/10.1002/ajh.22142
The paper
Ali, S. B., MooSang, M., King, L., Knight‐Madden, J., & Reid, M. (2011). Stroke recurrence in children with sickle cell disease treated with hydroxyurea following first clinical stroke. American Journal of Hematology. https://doi.org/10.1002/ajh.22142

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.